MktsMarkets

Citius Oncology, Inc.
NASDAQ: CTORKey statistics
CTOR News
Stories mentioning CTOR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,667 | 3,944 | ||||||
| Cost of Goods Sold | 329.00 | 789.00 | ||||||
| Gross Profit | 1,338 | 3,155 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,079 | 1,018 | 1,076 | 938.00 | 3,139 | 1,265 | 1,297 | 1,131 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 29,952 | 8,407 | 4,712 | 4,945 | 7,471 | 6,395 | 6,669 | 4,629 |
| Operating Income (Loss) | (28,614) | (5,252) | (4,712) | (4,945) | (7,471) | (6,395) | (4,629) | |
| Interest Income | 44.00 | 28.00 | ||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (26,841) | (5,270) | (4,732) | (5,106) | (7,471) | (6,395) | (6,669) | (4,629) |
| Tax Provision | (231.00) | 264.00 | 265.00 | 264.00 | 264.00 | 264.00 | 144.00 | 144.00 |
| Net Income (Loss) | (26,610) | (5,534) | (4,996) | (5,370) | (7,736) | (6,659) | (6,813) | (4,773) |
| Earnings Per Share (Basic) | (0.27) | (0.06) | (0.07) | (0.08) | (0.11) | (0.09) | (0.10) | (0.07) |
| Earnings Per Share (Diluted) | (0.27) | (0.06) | (0.07) | (0.08) | (0.11) | (0.09) | (0.10) | (0.07) |
| Weighted Average Shares Outstanding (Basic) | 100,027 | 87,462 | 73,268 | 71,552 | 71,552 | 71,552 | 68,054 | 67,500 |
| Weighted Average Shares Outstanding (Diluted) | 100,027 | 87,462 | 73,268 | 71,552 | 71,552 | 71,552 | 68,054 | 67,500 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTOR
Citius Oncology, Inc. (NASDAQ: CTOR) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTOR. It last traded at $0.5500 (Nov 9, 2026, 4:00 PM ET), up 7.8% on the day. That gives Citius Oncology a market capitalisation of $47.4M.
Over the past 52 weeks CTOR has traded between $0.4900 and $1.83.
Revenue for the quarter ended Mar 31, 2026 was $1.7M; a net loss of $26.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.7M | -$26.6M | -1596.3% |
| Dec 31, 2025 | $3.9M | -$5.5M | -140.3% |
| Sep 30, 2025 | — | -$5.0M | — |
| Jun 30, 2025 | — | -$5.4M | — |
From Citius Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…